This is a working overview of GW501516, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-08-25 and is reviewed periodically as new material appears.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Pakistan Horticulture Development & Export Board (PHDEC), an autonomous body under the administrative control of the Ministry of Commerce has been mandated with the development of the horticulture industry of Pakistan with a focus on exports. Its functions include the provision of improved marketing infrastructure like the establishment of agro-processing zones, cold chain system, processing plants for value-added products. The implementation arrangements are preferably under the public-private partnership (PPP) modality with a clear exit strategy. PHDEC envisions the vitalization of a dynamic and market-driven horticulture sector, which is resilient, sustainable and responsive to meet the challenges of globalization.
== External links == Isotopic effect Measurement In sugar solutions Why measure water activity? at the Wayback Machine (archived 2020-08-07) How to measure water activity? at the Wayback Machine (archived 2020-08-07)
The isotopes of nickel range in mass number from 48 (48Ni) to 82 (82Ni). Natural nickel is composed of five stable isotopes, 58Ni, 60Ni, 61Ni, 62Ni and 64Ni, of which 58Ni is the most abundant (68.077% natural abundance). Nickel-62 has the highest binding energy per nucleon of any nuclide: 8.7946 MeV/nucleon. Its binding energy is greater than both 56Fe and 58Fe, more abundant nuclides often incorrectly cited as having the highest binding energy. Though this would seem to predict nickel as the most abundant heavy element in the universe, the high rate of photodisintegration of nickel in stellar interiors causes iron to be by far the most abundant. Nickel-60 is the daughter product of the extinct radionuclide 60Fe (half-life 2.6 million years). Due to the long half-life of 60Fe, its persistence in materials in the Solar System may generate observable variations in the isotopic composition of 60Ni. Therefore, the abundance of 60Ni in extraterrestrial material may give insight into the origin of the Solar System and its early history. At least 26 nickel radioisotopes have been characterized; the most stable are 59Ni with half-life 76,000 years, 63Ni (100 years), and 56Ni (6 days). All other radioisotopes have half-lives less than 60 hours and most these have half-lives less than 30 seconds. This element also has one meta state. Radioactive nickel-56 is produced by the silicon burning process and later set free in large amounts in Type Ia supernovae.
=== September 2003 === Corporal Donald Payne of the Queen's Lancashire Regiment now the 1st Battalion, Duke of Lancaster's Regiment (King's, Lancashire and Border), became Britain's first convicted war criminal after pleading guilty to abusing Iraqi detainees, which resulted in the death of one detainee Baha Mousa.
Sources: en.wikipedia.org
Advances in genomics, biotechnology, and biodetection, including major contributions to the complete sequencing of the human genome though the Joint Genome Institute and the development of rapid PCR (polymerase chain reaction) technology that lies at the heart of today's most advanced DNA detection instruments. Development and operation of the National Atmospheric Release Advisory Center (NARAC), which provides real-time, multi-scale (global, regional, local, urban) modeling of hazardous materials released into the atmosphere. Development of highest resolution global climate models and contributions to the Intergovernmental Panel on Climate Change which, together with former vice president Al Gore, was awarded the 2007 Nobel Peace Prize. Co-discoverers of new superheavy elements 113, 114, 115, 116, 117, and 118. Invention of new healthcare technologies, including a microelectrode array for construction of an artificial retina, a miniature glucose sensor for the treatment of diabetes, and a compact proton therapy system for radiation therapy. On July 17, 2009 LLNL announced that the Laboratory had received eight R&D 100 Awards – more than it had ever received in the annual competition. The previous LLNL record of seven awards was reached five times – in 1987, 1988, 1997, 1998 and 2006. Also known as the "Oscars of invention", the awards are given each year for the development of cutting-edge scientific and engineering technologies with commercial potential. The awards raise LLNL's total number of awards since 1978 to 129.
Ranged combat is first-person, with character points assigned to the firearms skill determining the shot's accuracy and how long it takes to target an opponent. Melee combat is third-person, with access to weapons such as katanas and sledgehammers for melee combat, or pistols, crossbows, and flamethrowers for firearm combat. If a player sneaks up on an opponent, they can perform an instant kill; weapons provide unique instant kill animations. The player can block attacks manually or automatically by leaving their character idle. They can use stealth in missions by sneaking past guards and security cameras, picking locks, and hacking computers to locate alternative routes. Each clan has specific Disciplines, which can be used in combat and to create approaches to quests. Although some powers overlap clans, no two clans share the same three Disciplines. More physical vampires can enhance themselves to become fast and lethal killers or summon spirit allies to attack their foes; others can mentally dominate their targets to force their cooperation or render themselves invisible to hide from detection; and others can boil their opponent's blood from afar. The ability Blood Buff (which temporarily upgrades physical abilities) is common to all vampires. Several abilities can be active at the same time. Blood is a primary currency in Bloodlines, used to activate Disciplines and abilities.
== Research == SGLT2 inhibitors increase circulating ketone body concentrations. The cardioprotective effects of SGLT2 inhibitors have been attributed to the elevated ketone levels. Gliflozins have been posited to exhibit protective effects on the heart, liver, kidneys, anti‐hyperlipidemic, anti‐atherosclerotic, anti‐obesity, anti‐neoplastic effects in in vitro, pre‐clinical, and clinical studies. Pleiotropic effects of this class have been attributed to a variety of its pharmacodynamic actions such as natriuresis, hemoconcentration, deactivation of renin–angiotensin–aldosterone system, ketone body formation, alterations in energy homeostasis, glycosuria, lipolysis, anti‐inflammatory, and antioxidative actions. SGLT2 inhibitors have shown beneficial effects on liver function in clinical trials on individuals with NAFLD and type 2 diabetes, and also on those without type 2 diabetes. SGLT2 inhibitors also modified the adverse effects of ozone in heart failure, indicating a potential cardioprotective role. SGLT2 inhibitors have anti-inflammatory and immunomodulatory effects through pathways such as NF-κB, AMPK/mTOR, and JAK/STAT.
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.